ASN Press Releases

• Investigators have found that filtration markers used to estimate kidney function miss many cases of chronic kidney disease in individuals with cancer. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.

• Investigators have found that filtration markers used to estimate kidney function miss many cases of chronic kidney disease in individuals with cancer. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.

• An analysis of BESTOW trial results indicates that kidney transplant recipients treated with tegoprubart not only have better kidney function but also have better health-related quality of life than those taking today's standard of care immunosuppressive drug tacrolimus. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.

• Counties along the US–Mexico border have limited access to nephrology care, and this limited access is associated with higher chronic kidney disease-related mortality. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2026 October 22–25.

The American Society of Nephrology, has selected the following late breaking clinical trials to be presented in-person at Kidney Week 2026 October 22–25. The selected studies explore a wide range of kidney health issues, including transplantation and dialysis treatment, as well as emerging therapies and regimens to treat kidney diseases and co-morbidities.